Skip to content

Precigen

US · PGEN #2527 by market cap Listed 1970
4.21 +0.05 +1.20%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Precigen

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Founded
1998
CEO
Dr. Helen Sabzevari, PhD
Employees
47
Headquarters
Germantown, Maryland, United States of America
Fiscal year end
12-31
Website
precigen.com

Company profile

Exchange
US
Symbol
PGEN
Market-cap rank
#2527
Listing date
1970-01-01
Market cap
1.51B
Float cap
821.43M
Shares out
358.55M
Float shares
195.12M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Precigen discussion 0 comments

Add a comment